An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...
233,003 bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.
Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the presence of potentially ...
More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer.
The bottles were distributed nationwide, including in Wisconsin, and received the FDA's second-most severe risk ...
In three separate reports, the FDA said that various doses of duloxetine delayed-release capsules were recalled due to the ...
Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...
Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic ...
A New Jersey pharmaceutical company is recalling more than 230,000 bottles of duloxetine antidepressants after detecting a ...
The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain ...
The recommended dosage of duloxetine is 40 80 mg daily, depending on the indication, preferably split into two doses per day. For the treatment of major depression, duloxetine has achieved ...
For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...